Reduction in human melanoma cell adhesion receptor activity by lysophosphatidylcholine (LPC) treatment - functional characterization and signal pathway analyses.
Alexander
M
M
Department of Genomics, LIFE & BRAIN Center GmbH, Bonn, Germany. michael.alexander@uni-bonn.de
Schlesinger
M
M
Jantscheff
P
P
Massing
U
U
Bendas
G
G
D000368:Aged; D002448:Cell Adhesion / Q000187:drug effects; D045744:Cell Line, Tumor; D020869:Gene Expression Profiling; D006801:Humans; D016023:Integrins / Q000502:physiology; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D008545:Melanoma / Q000473:pathology / Q000556:secondary*; D015398:Signal Transduction / Q000187:drug effects*
D016023:Integrins; D008244:Lysophosphatidylcholines